Cargando…
ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390931/ https://www.ncbi.nlm.nih.gov/pubmed/33119438 http://dx.doi.org/10.18553/jmcp.2020.26.11.1464 |
| _version_ | 1785082586351009792 |
|---|---|
| author | Franklin, Meg Druyts, Eric |
| author_facet | Franklin, Meg Druyts, Eric |
| author_sort | Franklin, Meg |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10390931 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103909312023-08-02 ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine Franklin, Meg Druyts, Eric J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2020-11 /pmc/articles/PMC10390931/ /pubmed/33119438 http://dx.doi.org/10.18553/jmcp.2020.26.11.1464 Text en Copyright © 2020, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Value Franklin, Meg Druyts, Eric ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine |
| title | ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine |
| title_full | ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine |
| title_fullStr | ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine |
| title_full_unstemmed | ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine |
| title_short | ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine |
| title_sort | icer’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine |
| topic | Perspectives on Value |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390931/ https://www.ncbi.nlm.nih.gov/pubmed/33119438 http://dx.doi.org/10.18553/jmcp.2020.26.11.1464 |
| work_keys_str_mv | AT franklinmeg icersassessmentoflasmiditanrimegepantandubrogepantforacutemigraine AT druytseric icersassessmentoflasmiditanrimegepantandubrogepantforacutemigraine |